Gilead Unveils Pricing For Covid-19 Fighting Remdesivir
Gilead Unveils Pricing For Covid-19 Fighting Remdesivir

Gilead Sciences unveils what it calls 'below market' pricing for its anti-viral drug remdesivir, which has so far proven effective in treating Covid-19